Previous research suggests that state Medicaid expansions implemented under the Patient Protection and Affordable Care Act (ACA) helped large numbers of patients suffering from opioid use disorder (OUD) gain access to life-saving medications, including buprenorphine. However, Medicaid expansions...

Medication-assisted treatment (MAT) for opioid use disorder (OUD) consists of administering methadone, buprenorphine, or naltrexone in conjunction with behavioral therapy. Despite strong support in the medical and public health communities for MAT, fewer than 10 percent of US patients with...

Using administrative records of Medicaid enrollees in Rhode Island that link their health-care information with their payroll employment records, this paper produces new stylized facts concerning the association between opioid use disorder (OUD) and employment and inquires as to whether...